BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31677658)

  • 1. Malignant Hyperthermia: A Clinical Review.
    Kim KSM; Kriss RS; Tautz TJ
    Adv Anesth; 2019 Dec; 37():35-51. PubMed ID: 31677658
    [No Abstract]   [Full Text] [Related]  

  • 2. Malignant hyperthermia: a pharmacogenetic disorder.
    Stratman RC; Flynn JD; Hatton KW
    Orthopedics; 2009 Nov; 32(11):835. PubMed ID: 19902883
    [No Abstract]   [Full Text] [Related]  

  • 3. A rare genetic variant of the ryanodine receptor in a suspected malignant hyperthermia susceptible patient.
    MacKay EJ; Wilkerson C; Kraeva N; Rosenberg H; Kennedy T
    J Clin Anesth; 2016 Sep; 33():144-6. PubMed ID: 27555149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia: hot stuff!
    Noble KA
    J Perianesth Nurs; 2007 Oct; 22(5):341-5. PubMed ID: 17982793
    [No Abstract]   [Full Text] [Related]  

  • 5. [Malignant hyperthermia: pharmacogenetically caused acute massive rhabdomyolysis].
    Lebedinskiĭ KM; Triadskiĭ AA; Obolenskiĭ SV
    Anesteziol Reanimatol; 2008; (4):66-70. PubMed ID: 18819397
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant hyperthermia].
    Zimprich F; Kress HG; Zeitlhofer J
    Wien Klin Wochenschr; 2003 Sep; 115(15-16):556-62. PubMed ID: 14531168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Be prepared: malignant hyperthermia.
    DeJohn P
    OR Manager; 2008 Jun; 24(6):26-7, 30. PubMed ID: 18655686
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there a link between malignant hyperthermia and exertional heat illness?
    Muldoon S; Deuster P; Brandom B; Bunger R
    Exerc Sport Sci Rev; 2004 Oct; 32(4):174-9. PubMed ID: 15604937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
    Haugen T; Toft M; Müller CR; Aasly J
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant hyperthermia].
    Chastonay P; Bracco D; Freymond D; Ravussin P
    Rev Med Suisse Romande; 1999 Mar; 119(3):191-202. PubMed ID: 10218414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant hyperthermia].
    Metterlein T; Schuster F; Graf BM; Anetseder M
    Anaesthesist; 2014 Dec; 63(12):908-18. PubMed ID: 25384957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel alpha-1 subunit gene, and calsequestrin-1 gene polymorphisms.
    Capacchione JF; Sambuughin N; Bina S; Mulligan LP; Lawson TD; Muldoon SM
    Anesthesiology; 2010 Jan; 112(1):239-44. PubMed ID: 20010423
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed onset of malignant hyperthermia without creatine kinase elevation in a geriatric, ryanodine receptor type 1 gene compound heterozygous patient.
    Newmark JL; Voelkel M; Brandom BW; Wu J
    Anesthesiology; 2007 Aug; 107(2):350-3. PubMed ID: 17667581
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant hyperthermia.
    Denborough M
    Lancet; 1998 Oct; 352(9134):1131-6. PubMed ID: 9798607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and metabolic alterations in response to graded exercise in a patient susceptible to malignant hyperthermia.
    Wappler F; Fiege M; Antz M; Schulte am Esch J
    Anesthesiology; 2000 Jan; 92(1):268-72. PubMed ID: 10638927
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional Characterization of C-terminal Ryanodine Receptor 1 Variants Associated with Central Core Disease or Malignant Hyperthermia.
    Parker R; Schiemann AH; Langton E; Bulger T; Pollock N; Bjorksten A; Gillies R; Hutchinson D; Roxburgh R; Stowell KM
    J Neuromuscul Dis; 2017; 4(2):147-158. PubMed ID: 28527222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hyperthermia: successful management in a private surgery centre.
    Adamson PA; Dahiya R; Litner JA; Vosu H
    J Otolaryngol; 2006 Jun; 35(3):186-9. PubMed ID: 16929995
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant hyperthermia: how to spot it early.
    Haslego SS
    RN; 2002 Jul; 65(7):31-5; quiz 36. PubMed ID: 12136527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dantrolene use in 3,4-methylenedioxymethamphetamine (ecstasy)-mediated hyperthermia.
    Rusyniak DE; Banks ML; Mills EM; Sprague JE
    Anesthesiology; 2004 Jul; 101(1):263; author reply 264. PubMed ID: 15220814
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant hyperthermia.
    Carter-Templeton H
    Nursing; 2005 Jun; 35(6):88. PubMed ID: 15931134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.